| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee602c630e57f59c6cfc1c1634e36064 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H30-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2576-026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2576-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-742
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G08C23-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5601 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055 |
| filingDate |
2016-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48d93ea284db48667256f047ed091d05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47c1bf6d9b5a34579d16d334717e0cec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4e6acdeb32ba16f1edfcafc5c4c7f5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8100a9bc8d7fed567e5aa33aba2956a |
| publicationDate |
2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016270687-A1 |
| titleOfInvention |
System and Method for Quantitative Magnetic Resonance (MR) Analysis Using T1 Mapping |
| abstract |
Example apparatus and methods concern determining whether a target material appears in a region experiencing nuclear magnetic resonance (NMR). One method acquires a baseline value for a magnetic resonance parameter (MRP) while the region is not exposed to a molecular imaging agent that affects the MRP and acquires a series of quantitative values for the MRP while the sample is influenced by a molecular imaging agent. Quantitative values may be acquired during a clinically relevant time period (e.g., 60 minutes) during which the change in the MRP (e.g., T1) caused by the molecular imaging agent is at least 90% of the peak change caused by the molecular imaging agent. The molecular imaging agent may be SBK2 and may produce a desired change in T1 for at least thirty minutes in glioblastoma. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11442127-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10353040-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022053710-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016282433-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016313424-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018187760-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10718617-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10545209-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10725132-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9971006-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7315735-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3615056-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110739059-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3967221-A1 |
| priorityDate |
2013-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |